• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Respiratorius

2.83 SEK

+12.30 %

Less than 1K followers

RESP

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+12.30 %
+32.24 %
+113.58 %
+74.69 %
+74.69 %
-63.81 %
-88.98 %
-96.22 %
-80.22 %

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Read more
Market cap
22.36M SEK
Turnover
65.46K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
All
Press releases
ShowingAll content types

Financial calendar
11/8
2026

Interim report Q2'26

10/11
2026

Interim report Q3'26

9/2
2027

Annual report '26

Regulatory press release2026-06-09 17:47

Kommuniké från årsstämma den 9 juni 2026 i Respiratorius AB (publ)

Respiratorius
Regulatory press release2026-05-26 08:33

Respiratorius: Delårsrapport 1, 2026

Respiratorius
Regulatory press release2026-05-15 10:15

Respiratorius publicerar Årsredovisning för 2025

Respiratorius

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-05-06 11:15

Kallelse till årsstämma i Respiratorius AB (publ)

Respiratorius
Press release2026-03-05 16:15

Respiratorius: Styrelseledamot lämnar styrelsen av hälsoskäl

Respiratorius
Regulatory press release2026-02-10 08:33

Respiratorius: Bokslutskommuniké 2025

Respiratorius
Regulatory press release2025-12-04 08:57

Respiratorius: Valberedning inför årsstämman 2026 utsedd

Respiratorius
Regulatory press release2025-11-11 08:31

Respiratorius: Delårsrapport 3, 2025

Respiratorius
Regulatory press release2025-09-16 15:51

Sista dag för handel med BTA i Respiratorius

Respiratorius
Regulatory press release2025-09-11 17:07

Respiratorius offentliggör utfall av inlösen av teckningsoptioner serie TO2

Respiratorius
Regulatory press release2025-09-06 09:38

Respiratorius offentliggör utfall i företrädesemission

Respiratorius
Press release2025-09-02 15:06

Respiratorius VD ökar sitt deltagande i pågående företrädesemission - bolaget erhåller bekräftande FDA-protokoll och påminner om viktiga datum

Respiratorius
Regulatory press release2025-09-01 08:32

Respiratorius Receives Meeting Minutes from FDA Pre-IND Meeting

Respiratorius
Regulatory press release2025-09-01 08:32

Respiratorius erhåller mötesprotokoll från FDA:s pre-IND-möte

Respiratorius
Press release2025-08-28 08:14

BioStock: Läkare vill förskriva Respiratorius VAL001

Respiratorius
Regulatory press release2025-08-20 08:30

Respiratorius offentliggör informationsdokument avseende företrädesemission och information om TO2

Respiratorius
Regulatory press release2025-08-12 08:40

Respiratorius: Halvårsrapport 2025

Respiratorius
Regulatory press release2025-08-12 08:35

Respiratorius beslutar om en företrädesemission om cirka 18,9 MSEK

Respiratorius
Regulatory press release2025-08-12 08:30

Respiratorius has conducted a pre-IND meeting with the FDA

Respiratorius
Regulatory press release2025-08-12 08:30

Respiratorius har genomfört pre-IND-möte med FDA

Respiratorius